M Holdings Securities, Inc. - MYMD PHARMACEUTICALS INC ownership

MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 36 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
M Holdings Securities, Inc. ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$106
-13.1%
70,9090.0%0.02%
+69.2%
Q1 2023$122
+48.8%
70,9090.0%0.01%
+44.4%
Q4 2022$82
-100.0%
70,9090.0%0.01%
-55.0%
Q3 2022$185,000
+20.1%
70,9090.0%0.02%
+25.0%
Q2 2022$154,000
-53.3%
70,9090.0%0.02%
-36.0%
Q1 2022$330,000
-26.2%
70,9090.0%0.02%
-43.2%
Q2 2021$447,00070,9090.04%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NorthRock Partners, LLC 1,354,004$9,749,0000.80%
Shay Capital LLC 197,184$1,420,0000.18%
Corundum Group, Inc. 11,240$81,0000.06%
Mirae Asset Global Investments Co., Ltd. 1,132,131$8,151,0000.02%
Patriot Financial Group Insurance Agency, LLC 500$4,0000.00%
MORGAN STANLEY 668,151$4,811,0000.00%
WELLS FARGO & COMPANY/MN 2,956$21,0000.00%
NORTHERN TRUST CORP 56,561$407,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 279$2,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders